Abstract
This study identifies multiple copies of the AML1 gene on a duplicated chromosome 21, dup(21), as a recurrent abnormality in acute lymphoblastic leukemia (ALL). Clusters of AML1 signals were visible at interphase by fluorescence in situ hybridization (FISH). In metaphase, they appeared tandemly duplicated on marker chromosomes of five distinct morphological types: large or small acrocentrics, metacentrics, submetacentrics or rings. The markers comprised only chromosome 21 material. Karyotypes were near-diploid and, besides dup(21), no other established chromosomal changes were observed. A total of 20 patients, 1.5 and <0.5% among consecutive series of childhood and adult ALL respectively, showed this phenomenon. Their median age was 9 years, white cell counts were low and all had a pre-B/common immunophenotype. Although this series is not the first report of this abnormality, it is the largest, permitting a detailed description of the variety of morphological forms that duplicated chromosome 21 can assume.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263–4269.
Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989.
Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR et al. High incidence of TEL/AML1 fusion resulting from a cryptic t(12; 21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10: 991–993.
Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood 1997; 90: 571–577.
Dube ID, el Solh H . An apparent tandem quadruplication of chromosome 21 in a case of childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 1986; 23: 253–256.
Le Coniat M, Romana SP, Berger R . Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia. Genes Chromosome Cancer 1995; 14: 204–209.
Baialardo EM, Felice MS, Rossi J, Barreiro C, Gallego MS . Tandem triplication and quadruplication of chromosome 21 in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 1996; 92: 43–45.
Martineau M, Clark R, Farrell DM, Hawkins JM, Moorman AV, Secker-Walker LM . Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding. Genes Chromosome Cancer 1996; 17: 21–30.
Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S . AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia. Haematologica 2000; 85: 362–366.
Busson-Le Coniat M, Nguyen KF, Daniel MT, Bernard OA, Berger R . Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosome Cancer 2001; 32: 244–249.
Dal Cin P, Atkins L, Ford C, Ariyanayagam S, Armstrong SA, George R et al. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosome Cancer 2001; 30: 407–409.
Mathew S, Rao PH, Dalton J, Downing JR, Raimondi SC . Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia. Leukemia 2001; 15: 468–472.
Morel F, Herry A, Le Bris M-J, Douet-Guilbert N, Le Calvez G, Marion V et al. AML1 amplification in a case of childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 2002; 137: 142–145.
Penther D, Preudhomme C, Talmant P, Roumier C, Godon A, Mechinaud F et al. Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 2002; 16: 1131–1134.
Kakazu N, Taniwaki M, Horiike S, Nishida K, Tatekawa T, Nagai M et al. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosome Cancer 1999; 26: 336–345.
Hilgenfeld E, Padilla-Nash H, McNeil N, Knutsen T, Montagna C, Tchinda J et al. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2. Br J Haematol 2001; 113: 305–317.
Streubel B, Valent P, Lechner K, Fonatsch C . Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21. Cancer Genet Cytogenet 2001; 124: 42–46.
Mrozek K, Heinonen K, Theil KS, Bloomfield CD . Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Genes Chromosome Cancer 2002; 34: 137–153.
Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 1999; 93: 1817–1824.
Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166–175.
Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Takeuchi K, Maki K et al. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 2000; 96: 3154–3160.
Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 2000; 96: 2862–2869.
Kempski HM, Chessells JM, Reeves BR . Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia. Leukemia 1997; 11: 1973–1977.
Kempski HM, Craze JL, Chessells JM, Reeves BR . Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study. Br J Haematol 1998; 103: 473–479.
Harrison CJ, Martineau M, Secker-Walker LM . The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol 2001; 113: 3–10.
ISCN (1995). An International System for Human Cytogenetic Nomenclature, 1st edn. Basel: S Karger, 1995.
Najfeld V . Amplification of q22 chromosomal region of chromosome 21, including AML-1 gene, is a clonal marker in pediatric patients with acute lymphoblastic leukaemia (ALL). Blood 1998; 92: 396a.
Jabber Al-Obaidi MS, Martineau M, Bennett CF, Franklin IM, Goldstone AH, Harewood L et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 2002; 16: 669–674.
Mikhail FM, Serry KA, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM et al. AML1 gene over-expression in childhood acute lymphoblastic leukemia. Leukemia 2002; 16: 658–668.
Acknowledgements
We thank the Leukaemia Research Fund for financial support and the UK cytogenetics laboratories that contributed samples to this study: Belfast, Birmingham, Cambridge, Cardiff, Croydon, Dundee, Edinburgh, Great Ormond Street Children's Hospital, London, Manchester, Newcastle, Norwich, Royal Marsden Hospital, London, Salisbury, Sheffield, and University College Hospital, London. Cosmids ICRF c103 CO664 and H11086 were kindly donated by Dr Anne Hagermeijer, EU Concerted Action and Dr Roland Berger, Paris, respectively. We are grateful to Dr John Crolla and his team, Wessex Regional Genetics Laboratory, Salisbury for the growing and preparation of the AML1 specific cosmids as part of an ongoing collaboration. We thank Dr Helena Kempski for helpful discussions.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Harewood, L., Robinson, H., Harris, R. et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 17, 547–553 (2003). https://doi.org/10.1038/sj.leu.2402849
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402849
Keywords
This article is cited by
-
Runt-related transcription factors in human carcinogenesis: a friend or foe?
Journal of Cancer Research and Clinical Oncology (2023)
-
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Frontiers of Medicine (2021)
-
DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma
Blood Cancer Journal (2020)
-
MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia
Scientific Reports (2020)
-
MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL
Journal of Applied Genetics (2019)